2026-01-26 – Press Releases – www.prnewswire.com
TIANJIN, China, Jan. 26, 2026 /PRNewswire/ — In a landmark move for the cell therapy industry, a Device Master File (DMF) describing the first dedicated quality control standard for Mesenchymal Stromal Cells (MSCs) was accepted by the U.S. Food and Drug Administration (FDA). The agency’s…
